EQ Equillium, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$2.37
Price · Aug 19, 2026
Fundamentals as of Aug 13, 2026

EQ Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$2.37
Market Cap
$146M
P/E (TTM)
-6.1
EPS (TTM)
$-0.39
Revenue (TTM)
$41M
Div Yield
ROE
-133.1%
Debt/Equity
52W Range
$1 – $4

EQ Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $41M
3-point trend, +160.8%
2022-12-31 2024-12-31
EPS $-0.39
5-point trend, +71.3%
2021-12-31 2025-12-31
Free Cash Flow $-23M
8-point trend, -201.5%
2018-12-31 2025-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
EQ
Peer Median
P/E (TTM)
5-point trend, -43.4%
-6.1
P/S (TTM)
4-point trend, -9.7%
3.2
28.5
P/B
5-point trend, +99.5%
5.1
2.2
Price / FCF
5-point trend, -21.0%
-6.4

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
EQ
Peer Median
ROA
5-point trend, -70.4%
-77.9%
-100.0%
ROE
5-point trend, -142.5%
-133.1%
-154.7%
ROIC
5-point trend, -70.9%
-82.7%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
EQ
Peer Median
Current Ratio
5-point trend, +13.1%
10.6
2.9
Quick Ratio
5-point trend, +82.7%
10.3

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
EQ
Peer Median
Revenue YoY
3-point trend, +160.8%
13.9%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
EQ
Peer Median
EPS (Diluted)
5-point trend, +71.3%
$-0.39

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
EQ
Peer Median

EQ Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 18 analysts
  • Strong Buy 8 44.4%
  • Buy 9 50.0%
  • Hold 1 5.6%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

9 analysts · 2026-08-17
Median target $7.00 +195.4%
Mean target $8.56 +261.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.07%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.06 $-0.04 -0.02%
Dec. 31, 2025 $-0.04 $-0.06 0.02%
Sept. 30, 2025 $-0.06 $-0.15 0.09%
June 30, 2025 $-0.16 $-0.19 0.03%
March 31, 2025 $-0.24 $-0.35 0.11%
Dec. 31, 2024 $-0.16 $-0.32 0.16%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
EQ $95M -4.0 13.9% -133.1%
CNTB $159M -2.8 -99.8% -86687.5% -97.9%
TNYA $154M -1.2 -81.2%
CNTN $112M -2.7 -18.0%
HUMA
UNCY $128M -3.5 -29.0% -113.9%
HURA -1.2
SPRB $120M -1.7 -51.3% -139.9%
IMDX $215M -4.5 115.6% -1238.5% 330.8% 56.7%
INDP $6M -0.1 -2820.8%
OTLK $57M -0.6 -4416.2% 193.1% 4.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 15
Annual Income Statement data for EQ
Metric Trend 2025202420232022
Revenue 3-point trend, +160.8% · $41M $36M $16M
R&D Expense 2-point trend, -1.4% · · $37M $38M
SG&A Expense 4-point trend, -37.4% $11M $12M $14M $17M
Operating Expenses 4-point trend, -69.6% $24M $49M $51M $78M
Operating Income 4-point trend, +61.9% $-24M $-8M $-15M $-62M
Interest Income 4-point trend, +98.3% $833.0K $1M $2M $420.0K
Other Non-op 2-point trend, -127.0% · · $-76.0K $281.0K
Pretax Income 4-point trend, +64.1% $-22M $-8M $-13M $-62M
Income Tax 4-point trend, +0.00 $0 $361.0K $580.0K $0
Net Income 4-point trend, +64.1% $-22M $-8M $-13M $-62M
EPS (Basic) 4-point trend, +78.9% $-0.39 $-0.23 $-0.38 $-1.85
EPS (Diluted) 4-point trend, +78.9% $-0.39 $-0.23 $-0.38 $-1.85
Shares (Basic) 4-point trend, +69.9% 57,304,181 35,357,641 34,726,384 33,727,945
Shares (Diluted) 4-point trend, +69.9% 57,304,181 35,357,641 34,726,384 33,727,945
EBITDA 4-point trend, +61.9% $-24M $-8M $-15M $-62M
Balance Sheet 23
Annual Balance Sheet data for EQ
Metric Trend 2025202420232022
Cash & Equivalents 4-point trend, -48.8% $30M $18M $23M $59M
Receivables 3-point trend, -100.0% · $0 $4M $3M
Prepaid Expense 4-point trend, -73.5% $761.0K $2M $5M $3M
Other Current Assets 4-point trend, +2575.0% $214.0K $429.0K $235.0K $8.0K
Current Assets 4-point trend, -59.6% $31M $25M $49M $77M
PP&E (Net) 4-point trend, -58.1% $164.0K $262.0K $315.0K $391.0K
Accum. Depreciation 4-point trend, +125.7% $562.0K $499.0K $364.0K $249.0K
Other Non-current Assets 3-point trend, -74.0% $27.0K · $70.0K $104.0K
Total Assets 4-point trend, -59.3% $32M $26M $51M $78M
Accounts Payable 4-point trend, -81.0% $755.0K $3M $5M $4M
Accrued Liabilities 4-point trend, -74.9% $2M $3M $7M $7M
Short-term Debt · · · $6M
Current Liabilities 4-point trend, -90.8% $3M $6M $28M $32M
Capital Leases 4-point trend, -56.8% $356.0K $187.0K $384.0K $824.0K
Total Liabilities 4-point trend, -92.9% $3M $7M $28M $46M
Long-term Debt · · · $9M
Total Debt · · · $15M
Common Stock 4-point trend, +66.7% $5.0K $3.0K $3.0K $3.0K
Retained Earnings 4-point trend, -25.4% $-216M $-194M $-186M $-172M
AOCI 4-point trend, +377.6% $363.0K $781.0K $140.0K $76.0K
Stockholders' Equity 4-point trend, -10.5% $29M $19M $23M $32M
Liabilities + Equity 4-point trend, -59.3% $32M $26M $51M $78M
Shares Outstanding 4-point trend, +78.6% 61,464,368 35,557,563 35,254,752 34,414,149
Cash Flow 12
Annual Cash Flow data for EQ
Metric Trend 2025202420232022
D&A · · · $118.0K
Stock-based Comp 4-point trend, -52.0% $2M $4M $4M $5M
Deferred Tax · · · $0
Operating Cash Flow 4-point trend, -160.5% $-23M $-19M $-22M $-9M
CapEx 4-point trend, -82.8% $48.0K $85.0K $50.0K $279.0K
Investing Cash Flow 4-point trend, -76.1% $4M $14M $-5M $19M
Stock Repurchased · · $260.0K ·
Net Stock Activity · · $-260.0K ·
Financing Cash Flow 4-point trend, +2604.3% $30M $164.0K $-9M $-1M
Net Change in Cash 4-point trend, +39.5% $12M $-5M $-36M $9M
Taxes Paid $352.0K · · ·
Free Cash Flow 4-point trend, -152.9% $-23M $-19M $-22M $-9M
Profitability 7
Annual Profitability data for EQ
Metric Trend 2025202420232022
Operating Margin 3-point trend, +94.9% · -20.1% -40.2% -393.9%
Net Margin 3-point trend, +95.0% · -19.6% -37.0% -396.1%
Pretax Margin 3-point trend, +95.3% · -18.8% -35.4% -396.1%
EBITDA Margin 3-point trend, +94.9% · -20.1% -40.2% -393.9%
ROA 4-point trend, -2.2% -77.9% -21.2% -20.7% -76.2%
ROE 4-point trend, +35.9% -133.1% -38.2% -57.1% -207.7%
ROIC 4-point trend, +37.9% -82.7% -45.4% -67.3% -133.2%
Liquidity & Solvency 4
Annual Liquidity & Solvency data for EQ
Metric Trend 2025202420232022
Current Ratio 4-point trend, +341.7% 10.6 3.9 1.8 2.4
Quick Ratio 4-point trend, +433.7% 10.3 2.8 1.0 1.9
Debt / Equity · · · 0.5
LT Debt / Equity · · · 0.1
Efficiency 2
Annual Efficiency data for EQ
Metric Trend 2025202420232022
Asset Turnover 3-point trend, +461.1% · 1.1 0.6 0.2
Receivables Turnover 3-point trend, +98.1% · 22.0 11.0 11.1
Per Share 5
Annual Per Share data for EQ
Metric Trend 2025202420232022
Book Value / Share 4-point trend, -49.9% $0.47 $0.54 $0.64 $0.93
Revenue / Share 3-point trend, +148.8% · $1.16 $1.04 $0.47
Cash Flow / Share 4-point trend, -53.3% $-0.40 $-0.54 $-0.63 $-0.26
Cash / Share 4-point trend, -71.3% $0.49 $0.51 $0.66 $1.72
EPS (TTM) 4-point trend, +78.9% $-0.39 $-0.23 $-0.38 $-1.85
Growth Rates 1
Annual Growth Rates data for EQ
Metric Trend 2025202420232022
Revenue YoY 2-point trend, -89.2% · 13.9% 129.0% ·
Valuation (TTM) 14
Annual Valuation (TTM) data for EQ
Metric Trend 2025202420232022
Revenue TTM 4-point trend, +189.2% $46M $41M $36M $16M
Net Income TTM 4-point trend, +64.1% $-22M $-8M $-13M $-62M
Market Cap 4-point trend, +161.2% $95M $27M $25M $36M
Enterprise Value · · · $-8M
P/E 4-point trend, -593.6% -4.0 -3.3 -1.9 -0.6
P/S 4-point trend, -9.7% 2.1 0.6 0.7 2.3
P/B 4-point trend, +191.7% 3.3 1.4 1.1 1.1
P / Tangible Book 4-point trend, +191.7% 3.3 1.4 1.1 1.1
P / Cash Flow 4-point trend, -0.3% -4.2 -1.4 -1.2 -4.2
P / FCF 4-point trend, -3.3% -4.2 -1.4 -1.2 -4.0
EV / EBITDA · · · 0.1
EV / FCF · · · 0.9
EV / Revenue · · · -0.5
Earnings Yield 4-point trend, +85.6% -25.2% -30.7% -52.8% -174.5%

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $41M$36M$16M
Operating Margin % -20.1%-40.2%-393.9%
Net Income $-22M$-8M$-13M$-62M$-39M
Diluted EPS $-0.39$-0.23$-0.38$-1.85$-1.36
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.50.2
Current Ratio 10.63.91.82.49.4
Quick Ratio 10.32.81.01.95.6
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-23M$-19M$-22M$-9M$-32M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 72 filers · $130.2M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
24 (+7 vs prior Q) 8 (+5 vs prior Q) 14 (+5 vs prior Q) 17 (+5 vs prior Q) -3.4M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Decheng Capital LLC $14,231,386 4,447,308 10.93% Shares
Affinity Asset Advisors, LLC $13,120,000 4,100,000 10.07% Shares
JANUS HENDERSON GROUP PLC $12,956,669 6,494,571 9.95% Shares
ADAR1 Capital Management, LLC $12,027,421 3,758,569 9.23% Shares
Aberdeen Group plc $11,621,309 3,631,659 8.92% Shares
Woodline Partners LP $11,202,883 3,500,901 8.60% Shares
RA CAPITAL MANAGEMENT, L.P. $9,908,275 3,096,336 7.61% Shares
STEMPOINT CAPITAL LP $6,453,142 2,016,607 4.95% Shares
VANGUARD CAPITAL MANAGEMENT LLC $5,832,998 1,822,812 4.48% Shares
Eversept Partners, LP $4,866,637 1,520,824 3.74% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $4,448,810 1,390,253 3.42% Shares
VANGUARD GROUP INC $2,673,854 1,725,067 2.05% Shares
TAKEDA PHARMACEUTICAL CO LTD $2,609,717 1,824,977 2.00% Shares
RENAISSANCE TECHNOLOGIES LLC $2,040,374 637,617 1.57% Shares
Exome Asset Management LLC $1,769,459 552,956 1.36% Shares
DG Capital Management, LLC $1,482,867 463,396 1.14% Shares
DIADEMA PARTNERS LP $1,280,902 400,282 0.98% Shares
Balyasny Asset Management L.P. $1,102,109 344,409 0.85% Shares
TUDOR INVESTMENT CORP ET AL $1,024,320 320,100 0.79% Shares
GEODE CAPITAL MANAGEMENT, LLC $994,780 310,682 0.76% Shares
Ikarian Capital, LLC $971,376 303,555 0.75% Shares
BOOTHBAY FUND MANAGEMENT, LLC $909,856 284,330 0.70% Shares
TWO SIGMA INVESTMENTS, LP $661,930 206,853 0.51% Shares
VANGUARD FIDUCIARY TRUST CO $610,592 190,810 0.47% Shares
STATE STREET CORP $556,992 174,060 0.43% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $478,080 149,400 0.37% Put option
CANTOR FITZGERALD, L. P. $348,998 109,062 0.27% Shares
Persistent Asset Partners Ltd $326,432 102,010 0.25% Shares
CITADEL ADVISORS LLC $318,918 99,662 0.24% Shares
Soleus Capital Management, L.P. $288,000 90,000 0.22% Shares
RAYMOND JAMES FINANCIAL INC $237,632 74,260 0.18% Shares
NORTHERN TRUST CORP $228,989 71,559 0.18% Shares
Cota Capital Management, LLC $177,230 562,278 0.14% Shares
AlphaCore Capital LLC $167,504 52,345 0.13% Shares
JANE STREET GROUP, LLC $149,440 46,700 0.11% Put option
ExodusPoint Capital Management, LP $141,405 44,189 0.11% Shares
JANE STREET GROUP, LLC $141,120 44,100 0.11% Call option
MILLENNIUM MANAGEMENT LLC $137,082 42,838 0.11% Shares
XTX Topco Ltd $125,642 39,263 0.10% Shares
Invesco Ltd. $116,131 36,291 0.09% Shares
BARCLAYS PLC $112,000 35,000 0.09% Shares
JANE STREET GROUP, LLC $111,926 34,977 0.09% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $111,040 34,700 0.09% Call option
Jefferies Financial Group Inc. $109,120 34,100 0.08% Shares
High Net Worth Advisory Group LLC $107,200 33,500 0.08% Shares
CITIGROUP INC $104,624 32,695 0.08% Shares
Quadrature Capital Ltd $91,696 28,655 0.07% Shares
AMERICAN CENTURY COMPANIES INC $82,864 25,895 0.06% Shares
China Universal Asset Management Co., Ltd. $80,000 25,000 0.06% Shares
TWO SIGMA ADVISERS, LP $68,355 44,100 0.05% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $67,875 21,211 0.05% Shares
Chung Wu Investment Group, LLC $52,800 16,500 0.04% Shares
CITADEL ADVISORS LLC $52,480 16,400 0.04% Put option
DIMENSIONAL FUND ADVISORS LP $49,066 15,333 0.04% Shares
Coastal Bridge Advisors, LLC $48,000 15,000 0.04% Shares
Apollon Wealth Management, LLC $44,400 13,875 0.03% Shares
Focus Partners Wealth $41,642 13,013 0.03% Shares
Callan Capital, LLC $39,108 99,688 0.03% Shares
TWO SIGMA SECURITIES, LLC $34,550 10,797 0.03% Shares
BlackRock, Inc. $31,552 9,860 0.02% Shares
Vanguard Global Advisers, LLC $18,643 5,826 0.01% Shares
MORGAN STANLEY $17,162 5,363 0.01% Shares
Tower Research Capital LLC (TRC) $7,632 2,385 0.01% Shares
GROUP ONE TRADING LLC $7,162 2,238 0.01% Shares
WELLS FARGO & COMPANY/MN $3,200 1,000 0.00% Shares
JONES FINANCIAL COMPANIES LLLP $1,525 500 0.00% Shares
Caitong International Asset Management Co., Ltd $749 234 0.00% Shares
MERCER GLOBAL ADVISORS INC /ADV $326 102 0.00% Shares
SBI Securities Co., Ltd. $218 68 0.00% Shares
UBS Group AG $128 40 0.00% Shares
HRT FINANCIAL LP $86 26,978 0.00% Shares
HUNTINGTON NATIONAL BANK $42 1 0.00% Shares

Company insiders 16 insiders · 9 officers · 8 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Bruce D. Steel President and CEO Jan. 2, 2024 A 48,495 0 0 $0
Jason A Keyes Chief Financial Officer Jan. 2, 2024 A 58,913 0 0 $0
Stephen Connelly President and CSO June 4, 2026 S 762,025 0 1 $-632,760
Christine Zedelmayer Sr. Vice President and COO June 5, 2026 M 62,586 0 2 $-69,254
Penny Tom Principal Accounting Officer May 28, 2026 M 0 0 1 $-191,750
Daniel Bradbury CHAIRMAN May 28, 2026 A 2,969,596 0 0 $0
Joel Rothman Chief Development Officer Jan. 2, 2024 A 58,150 0 0 $0
Dolca Thomas Chief Medical Officer Jan. 11, 2021 A 0 0 $0
Krishna R Polu Chief Medical Officer April 22, 2020 A 0 0 $0
Charles Douglas Mcdermott Director May 28, 2026 A 0 0 $0
Barbara Troupin Director May 28, 2026 A 0 0 $0
Mark Pruzanski Director May 28, 2026 A 0 0 $0
Martha J Demski Director May 28, 2026 A 0 0 $0
Yu (Katherine) Xu Director May 22, 2023 A 0 0 $0
Bala S Manian Director May 22, 2023 A 0 0 $0
Biocon SA 10% owner Oct. 16, 2018 A 2,316,134 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Decheng Capital Global Life Sciences Fund IV, L.P., Decheng Capital Management IV (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Xiangmin Cui Feb. 16, 2021 Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 6 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
QQQS · Invesco Exchange-Traded Fund Trust … 0.36% 38,559 SH Aug. 8, 2026 Daily
IWC · iShares Trust 0.02% 147,697 SH Aug. 8, 2026 Daily
AVSC · AMERICAN CENTURY ETF TRUST 0.00% 10,623 NS May 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.00% 7,665 NS April 30, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 373,367 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 1,401,958 SH Aug. 8, 2026 Daily